Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes

NCT00308737 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2053

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes, Type 1
Diabetes, Type 2

Interventions

DRUG: Technosphere® Insulin Inhalation Powder
DRUG: Usual Care

Sponsor

Mannkind Corporation